The markets closed flat with the Dow adding 3 points to 18,533 as worker productivity slipped in the second quarter. Nasdaq rose 12 points to 5,225.
On the upside
Castlight Health (NYSE: CSLT) narrowed losses for the second quarter as revenue rose.
Valeant Pharmaceuticals (NYSE: VRX) received an unsolicited offer for its core assets.
Endo International (Nasdaq: ENDP) swung to a profit for the second quarter as revenue climbed.
On the downside
Array BioPharma (Nasdaq: ARRY) development partner AstraZeneca (NYSE: AZN) reported disappointing results from a Phase III study of the lung cancer treatment selumetinib.
Manitowoc (NYSE: MTW) fell to a loss for the second quarter as revenue slipped.
TubeMogul (Nasdaq: TUBE) widened losses more than expected for the second quarter.
In the broad market, advancing issues outpaced decliners by a margin of more than 10 to 9 on the NYSE and by 9 to 7 on Nasdaq. The broader S&P 500 edged up a fraction to 2,181. Bitcoin lost $4 to $583.
